VYGR Operating Cash Flow (Statement)
Voyager Therapeutics Inc · Operating Cash Flow (Statement)
VYGR Operating Cash Flow (Statement)
Latest reported-$25.84Mperiod ending
VYGR Quarterly Cash from Operations (-$2.53M → -$25.84M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
VYGR operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -25,842,000 | |
| -33,419,000 | |
| -30,263,000 | |
| -31,048,000 | |
| -33,261,000 | |
| -37,895,000 | |
| -14,529,000 | |
| -27,968,000 | |
| -31,580,000 | |
| 58,767,000 | |
| -23,760,000 | |
| -21,051,000 | |
| -835,000 | |
| 123,565,000 | |
| -12,244,000 | |
| -16,206,000 | |
| -18,485,000 | |
| 34,426,000 | |
| 11,195,000 | |
| -20,709,000 | |
| -22,717,000 | |
| -21,294,000 | |
| -21,977,000 | |
| -24,740,000 | |
| -21,201,000 | |
| -28,798,000 | |
| -23,360,000 | |
| -21,579,000 | |
| -31,557,000 | |
| 125,162,000 | |
| -24,348,000 | |
| -17,647,000 | |
| -22,502,000 | |
| 48,610,000 | |
| -14,834,000 | |
| -15,887,000 | |
| -16,335,000 | |
| -14,294,000 | |
| -13,092,000 | |
| -10,189,000 | |
| -9,714,000 | |
| -9,487,000 | |
| -9,557,000 | |
| -6,750,000 | |
| -6,982,000 | |
| 64,588,000 | |
| -4,792,000 | |
| -2,329,000 | |
| -2,263,000 | |
| -2,534,000 |